Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
54.3% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
New
narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
7.2% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
25.3% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.4% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Burjeel Holdings
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Rising Health Awareness And Telemedicine Will Expand MENA Healthcare
Key Takeaways Rapid expansion in high-growth specialties and mental health is unlocking new high-margin revenue streams and driving faster-than-expected profit growth. Asset-light international partnerships and advanced healthcare technology investments are structurally improving efficiency, patient volumes, and long-term profitability.
View narrative
د.إ2.88
FV
49.0% undervalued
intrinsic discount
10.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Welspun
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Global Infrastructure Trends And Clean Energy Will Boost Pipe Demand
Key Takeaways Welspun is positioned for sustained revenue and margin growth through global market share gains, premium products, and strategic capacity additions supported by favorable policy trends. Expansion into specialty segments and polymer pipes, along with operational improvements, could drive significant cash flow increases and make current valuations seem undervalued.
View narrative
₹1.19k
FV
25.4% undervalued
intrinsic discount
26.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Cargojet
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
E-commerce Expansion Will Empower Air Cargo Networks Worldwide
Key Takeaways Cargojet's first-mover advantage and exclusive long-term partnerships with global clients uniquely position it to benefit from shifting trade routes and e-commerce growth. Operational efficiency, a technology-driven culture, and a strengthened network are expected to boost margins, diminish cyclicality, and drive sustained market share gains.
View narrative
CA$170.00
FV
40.8% undervalued
intrinsic discount
4.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Agios Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Precision Therapies Will Serve Aging Populations While Facing Regulatory Delays
Key Takeaways Accelerated global expansion and rapid market adoption are fueled by strong partnerships, clear patient targeting, and proactive payer and clinician engagement. Multiple near-term clinical advancements and pipeline synergies position Agios for transformative revenue growth and margin improvement, surpassing standard industry progress.
View narrative
US$57.00
FV
34.6% undervalued
intrinsic discount
122.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Grupo México. de
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Global Electrification And Urbanization Will Fuel Copper Demand
Key Takeaways Upcoming projects in Peru and ongoing cost reductions position the company for industry-leading margin expansion amid a supportive global copper environment. Robust balance sheet and strategic focus on core investments, including ESG leadership and transportation, support sustained growth, resilience, and institutional investor appeal.
View narrative
Mex$167.81
FV
25.7% undervalued
intrinsic discount
6.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
PostNL
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Digitalization And E-Commerce Will Enable Sustainable Parcel Advances
Key Takeaways Expansion of parcel lockers, digitalization, and automation are expected to significantly enhance margins and earnings resilience by reducing costs and supporting scale. Strong ESG credentials and a shift to an asset-light, cross-border delivery model boost revenue growth prospects and set PostNL apart from slower competitors.
View narrative
€1.20
FV
18.8% undervalued
intrinsic discount
2.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Mitsui Chemicals
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Regulatory Crackdowns And Supply Chain Strains Will Hobble Basic Materials
Key Takeaways The global shift toward sustainability and regulatory crackdowns are eroding demand and margins for Mitsui Chemicals' core petrochemical businesses, threatening its long-term earnings. Delays in pivoting to higher-value sustainable solutions amid restructuring efforts expose Mitsui Chemicals to market share loss, rising costs, and persistent earnings volatility.
View narrative
JP¥3.00k
FV
22.0% overvalued
intrinsic discount
-0.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Vitru Brasil Empreendimentos Participações e Comércio
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Digital Expansion Will Fuel Brazilian Lifelong Learning Amid Competitive Risks
Key Takeaways Vitru's scale, operational agility, and investment in digital platforms position it to outpace competitors in enrollment growth and capture significant market share amid regulatory shifts. Sustained high margins, expanding nationwide reach, and alignment with workforce demand drive resilient earnings power and long-term revenue growth above industry expectations.
View narrative
R$18.00
FV
42.8% undervalued
intrinsic discount
4.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Alembic Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Aging Populations And Emerging Markets Will Transform Pharmaceutical Opportunities
Key Takeaways Strong new product launches, pipeline scaling, and strategic focus on complex generics position Alembic for significant outperformance in revenue and earnings. Investments in specialized therapeutics and operational excellence enhance margin expansion and solidify market leadership amid industry consolidation.
View narrative
₹1.34k
FV
26.9% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies